(Q28321430)

https://api.crossref.org/works/10.1016/0166-3542(91)90030-U

21 October 2022

author name string

B. B. Barnett

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1650165

21 October 2022

N. J. Burns

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1650165

21 October 2022

K. J. Park

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1650165

21 October 2022

M. I. Dawson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1650165

21 October 2022

M. Kende

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1650165

21 October 2022

R. W. Sidwell

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1650165

full work available at URL

21 October 2022

language of work or name

English

0 references

publication date

February 1991

0 references

https://api.elsevier.com/content/article/PII:016635429190030U?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90030-U

https://api.elsevier.com/content/article/PII:016635429190030U?httpAccept=text/plain

21 October 2022

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90030-U

21 October 2022

0 references

15

0 references

issue

2

0 references

page(s)

125-38

0 references

cites work

Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cells

3

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90030-U

Monoclonal antibody and an antibody-toxin conjugate to a cell surface proteoglycan of melanoma cells suppress in vivo tumor growth

21 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90030-U

A newly developed immunofluorescent assay for determining the Pichinde virus-inhibitory effects of selected nucleoside analogues

21 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90030-U

Selective killing of HIV-infected cells by recombinant human CD4-Pseudomonas exotoxin hybrid protein

21 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90030-U

21 October 2022

Immunotoxins

8

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90030-U

Preparation of antibody-toxin conjugates

21 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90030-U

Properties of the ribosome-inactivating proteins gelonin, Momordica charantia inhibitor, and dianthins

21 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90030-U

Selective killing of HIV-infected cells by anti-gp120 immunotoxins

21 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90030-U

An efficient mRNA-dependent translation system from reticulocyte lysates

21 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90030-U

The antileukemic efficacy of an immunotoxin composed of a monoclonal anti-Thy-1 antibody disulfide linked to the ribosome-inactivating protein gelonin

21 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90030-U

Cytotoxicity acquired by conjugation of an anti-Thy1.1 monoclonal antibody and the ribosome-inactivating protein, gelonin

21 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90030-U

HIV-infected cells are killed by rCD4-ricin A chain

21 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90030-U

The use of immunotoxins containing ricin A or B chains to kill neoplastic B cells

21 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0166-3542(91)90030-U

21 October 2022

Identifiers

0 references